Technology
Health
Pharmaceutical
Liquidia Technologies
$9.629876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$9.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.67 (-6.51%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell LQDA and other stocks, options, ETFs, and crypto commission-free!
About
Liquidia Technologies, Inc. Common Stock, also called Liquidia Technologies, is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. Read More It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded in 2004 and is headquartered in Durham, NC.
Employees
—
Headquarters
Morrisville, North Carolina
Founded
2004
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
84.18K
High Today
$10.15
Low Today
$9.06
Open Price
$10.15
Volume
51.83K
52 Week High
$38.46
52 Week Low
$8.01
Collections
Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Therapy
2018 IPO
US
News
Seeking AlphaMay 6
Liquidia Technologies Inc. (LQDA) CEO Neal Fowler on Q1 2019 Results - Earnings Call Transcript
Liquidia Technologies Inc. (NASDAQ:LQDA) Q1 2019 Earnings Conference Call May 2, 2019 8:00 AM ET Company Participants Jenny Kobin - IR Neal Fowler - CEO Tim Albury - CFO Robert Roscigno - SVP, Product Development & Program Lead for LIQ861 Conference Call Participants Stacy Ku - Cowen & Company Liana Moussatos - Wedbush Securities Serge Belanger - Needham & Company Chris Howerton - Jefferies Operator Good day, ladies and gentlemen, and welcome to the Liquidia First Quarter 2019 Financial Results ...
Price Paid on Robinhood
28% Lower
Right Now
52 Week Low
$8.01
Average Price Paid
$13.33
52 Week High
$38.46
Earnings
-$0.87
-$0.77
-$0.67
-$0.57
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Estimated
—
Actual
Expected Jul 22, Pre-Market